These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23471065)

  • 21. Research funding. Prizes eyed to spur medical innovation.
    Travis J
    Science; 2008 Feb; 319(5864):713. PubMed ID: 18258868
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotech patent landscapes: a reflection of global innovation?
    Mueller H
    Pharm Pat Anal; 2015; 4(5):349-50. PubMed ID: 26389726
    [No Abstract]   [Full Text] [Related]  

  • 23. The CREATE Act: increasing costs associated with the biotech industry?
    Mills AE; Chen DT; Gillon JJ; Tereskerz PM
    Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creating a winning patent portfolio.
    Praiss DM
    Nat Biotechnol; 2001 Jul; 19 Suppl():BE5-7. PubMed ID: 11433233
    [No Abstract]   [Full Text] [Related]  

  • 25. The National University of Singapore and what it does.
    Halliwell B
    Biointerphases; 2010 Sep; 5(3):FA15-8. PubMed ID: 21171707
    [No Abstract]   [Full Text] [Related]  

  • 26. Human neuroimaging and the BRAIN initiative: a joint statement from the ASNR and ASFNR, with the support of the RSNA, ACR, ARR, and ISMRM.
    Sze G; Wintermark M; Law M; Mukherjee P; Hess C
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):213-4. PubMed ID: 24436343
    [No Abstract]   [Full Text] [Related]  

  • 27. Academic industry relationships in biotechnology: a primer on policy and practice.
    Campbell EG; Blumenthal D
    Cloning; 2000; 2(3):129-36. PubMed ID: 16218849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patents: a tool to bring innovation from the lab bench to the marketplace.
    Li ZY; Meyer W
    Methods Mol Biol; 2014; 1152():297-310. PubMed ID: 24744041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical innovation as the driver of change in academic surgery.
    Jain M; Gewertz BL
    Surgery; 2019 Nov; 166(5):717-720. PubMed ID: 30773219
    [No Abstract]   [Full Text] [Related]  

  • 30. Tech transfer-slow progress.
    Lawrence S
    Nat Biotechnol; 2005 Jan; 23(1):12. PubMed ID: 15637603
    [No Abstract]   [Full Text] [Related]  

  • 31. Singapore and the Nanyang Technological University--A young country with a young university on the move.
    Andersson B; Mayer T
    Biointerphases; 2010 Sep; 5(3):FA9-14. PubMed ID: 21171719
    [No Abstract]   [Full Text] [Related]  

  • 32. Biomedical science: Houston has lift-off.
    Smaglik P
    Nature; 2014 Aug; 512(7514):339-40. PubMed ID: 25147885
    [No Abstract]   [Full Text] [Related]  

  • 33. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of the US Patent System on the promise of personalized medicine.
    Solomon LM; Sieczkiewicz GJ
    Gend Med; 2007 Sep; 4(3):187-92. PubMed ID: 18022586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Price controls for medical innovations in a life cycle perspective.
    Sorek G
    Health Econ; 2014 Jan; 23(1):108-16. PubMed ID: 23339083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is academic medicine for sale?
    Angell M
    N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191
    [No Abstract]   [Full Text] [Related]  

  • 37. What is your reasonable expectation of success in obtaining pharmaceutical or biotechnology patents having nonobvious claimed inventions that the courts will uphold? An overview of obviousness court decisions.
    Pereira DJ; Kunin SG
    Cold Spring Harb Perspect Med; 2014 Dec; 5(4):. PubMed ID: 25475106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
    Caulfield T
    Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021
    [No Abstract]   [Full Text] [Related]  

  • 39. In focus: biointerphase science in Singapore.
    Liedberg B; Knoll W
    Biointerphases; 2010 Sep; 5(3):FA1. PubMed ID: 21171702
    [No Abstract]   [Full Text] [Related]  

  • 40. A blessing in disguise: international standards for the biotechnology industry.
    Lonien J
    Biotechnol J; 2012 Nov; 7(11):1321-3. PubMed ID: 23047846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.